Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
Oxford University Hospitals NHS Trust · Science Oxford · +4 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 75.25
- Percentile
- 100%
- References
- 46
Authors
7- UCUsha ChakravarthyCorresponding
Oxford University Hospitals NHS Trust, Science Oxford, University of Bristol, Queen's University Belfast, University of Liverpool, University of Southampton
- SHSimon Harding
University of Bristol, Queen's University Belfast, Science Oxford, Oxford University Hospitals NHS Trust, University of Liverpool, University of Southampton
- CRChris Rogers
Science Oxford, Queen's University Belfast, Oxford University Hospitals NHS Trust, University of Southampton, University of Bristol, University of Liverpool
- SMSusan M. Downes
University of Bristol, Queen's University Belfast, Oxford University Hospitals NHS Trust, University of Liverpool, University of Southampton, Science Oxford
- ALAndrew Lotery
University of Liverpool, University of Southampton, Science Oxford, University of Bristol, Queen's University Belfast, Oxford University Hospitals NHS Trust
Topics & keywords
- Medicine
- VEGF receptors
- Randomized controlled trial
- Ophthalmology
- Choroidal neovascularization
- Macular degeneration
- Ranibizumab
- Optometry
- Good health and well-being